A cardiologist by training, Nathan has been with Frazier Healthcare Partners since 1999. He has led or co-led exited investments including BARRX, (acquired by Covidien), Zeltiq (NASDAQ: ZLTQ), Glaukos (NASDAQ: GKOS), Packaging Coordinators Inc. (PCI) (acquired by The Partners Group), Abode Healthcare (acquired by Tailwind Capital), Silvergate Pharma (acquired by CutisPharma), Powervision (acquired by Alcon), and The CORE Institute (acquired by Audax Group and Linden Capital Partners). He currently serves on the boards of United Derm Partners, PCI, Leiters, Vein Clinics of America, Caravel Autism Health, and Comprehensive Pharmacy Services. He also serves on the PRI Investment Committee for the Bill and Melinda Gates Foundation.
Prior to joining Frazier, Nathan was an Associate Professor of Medicine and the Director of the Cardiovascular Outcomes Research Center (CORC) at the University of Washington.
Emory University School of Medicine (M.D.)
University of Washington School of Public Health (M.P.H.)
University of Pennsylvania (B.A.)